Features
MPR reports on the impacts of elevated body mass index (BMI) on drug dosing.
Features
This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.
Features
The FDA decision that 23andMe's Saliva Collection Kit and Personal Genome Service (PGS) should be classified as a medical device was highly controversial. Two experts weigh in on this complex issue.
Features
Although use of dietary supplements is not always recommended, it is best for clinicians to be knowledgeable about the safety and efficacy data surrounding them in order to assist patients who choose to use them.